High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia. - Wikidata - wikimedia - TriplyDB

High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia.

High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia.

http://www.wikidata.org/entity/Q54309630

about

High-throughput sequencing of immune repertoires in multiple sclerosis Novel technologies and emerging biomarkers for personalized cancer immunotherapy Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies Making the genomic leap in HCT: application of second-generation sequencing to clinical advances in hematopoietic cell transplantation Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells Next generation sequencing: new tools in immunology and hematology Advancing the Minimal Residual Disease Concept in Acute Myeloid Leukemia Integrative network modeling approaches to personalized cancer medicine A bioinformatic framework for immune repertoire diversity profiling enables detection of immunological status VDJviz: a versatile browser for immunogenomics data.Digital genomic quantification of tumor-infiltrating lymphocytes.Impact of next-generation sequencing error on analysis of barcoded plasmid libraries of known complexity and sequence.Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing.Next generation MRD.Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas.Unifying immunology with informatics and multiscale biology.Fast multiclonal clusterization of V(D)J recombinations from high-throughput sequencing.Characterizing immune repertoires by high throughput sequencing: strategies and applications.Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia.Comprehensive analysis of the T-cell receptor beta chain gene in rhesus monkey by high throughput sequencing IMSEQ--a fast and error aware approach to immunogenetic sequence analysis.Detection and Tracking of NY-ESO-1-Specific CD8+ T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient.VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires.End of induction minimal residual disease alone is not a useful determinant for risk stratified therapy in pediatric T-cell acute lymphoblastic leukemia.A Public Database of Memory and Naive B-Cell Receptor Sequences Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.Methodologic Considerations in the Application of Next-Generation Sequencing of Human TRB Repertoires for Clinical Use.Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia.Measurements of treatment response in childhood acute leukemia.High-throughput sequencing of B- and T-lymphocyte antigen receptors in hematology.Molecular and genetic inflammation networks in major human diseases.Minimal Residual Disease Detection and Evolved IGH Clones Analysis in Acute B Lymphoblastic Leukemia Using IGH Deep Sequencing.The past, present, and future of immune repertoire biology - the rise of next-generation repertoire analysis.Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lymphocyte leukemia identifies signature landscapes.Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH.Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival.Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy.Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia.Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation.

P2860

Q26747682-5804B170-3A63-40B9-A071-240367B802B8 Q26770780-2D142A04-1A70-4446-A195-5669B75FBDF2 Q26828511-32CE48FE-FEA1-4445-970D-7F83AD718EA6 Q27002964-D73F4015-99EF-4EF1-8078-CA6E70F6DC2E Q27013972-309D7F2C-B173-4DCC-8DF6-AB298C61BA1A Q27025231-68DF562F-F530-47D2-B54B-282E0B0CC0B9 Q28087291-00B6F97D-7F61-4C89-8CA5-DFBE5C231272 Q28602016-21F35DE0-E8AE-4E3D-94E5-3CACDE1555D6 Q28647646-E5D18F6E-EF5C-4F4C-B5E1-513F3E37230D Q31107890-8D273F89-0773-4995-8791-033360E813F2 Q33631158-2D138B81-F8E7-4727-8492-C9BB30C8258B Q34249667-E0EB5C38-5A44-4B47-BC19-9BD80BCD384B Q34364350-06D7E275-EC13-4039-B9CF-BA922CB7D0EC Q34406955-441298DF-B79A-4D82-ACD5-86E2F78D6E66 Q34559389-F01C6D4D-5B5E-4520-80C1-7B1BAA724E15 Q35134186-CD128B8B-0E3A-4A02-894D-62DA43F39E10 Q35178180-97124523-31DF-4107-8C11-58CC2AAFA266 Q35327599-6E5EBDC7-537B-497E-9A32-15457A6D9B09 Q35377918-35E5F1C4-BC7D-433F-9A27-28EE4FF43E3A Q35591194-BC30EB9D-A570-4286-B228-A21BEC950851 Q35634815-68D0D1C5-2FC3-433C-BCA5-CEAAC60D5E70 Q35751259-3D0026C8-C55B-4789-9F3A-A97FE0E968BF Q35852353-5CBECB17-A599-47B5-BEA8-EF65C51B971B Q36093798-5A972F64-DF42-4867-8D8E-783CA54DC3D6 Q36101141-121F2688-3346-4878-A0C4-09016F67EB7C Q36182008-CC3D43A7-2505-49A2-900B-B06EB7C01440 Q36183310-67488069-00A3-4B6F-AD48-4D6FDF3EF828 Q36509641-CB82AC2B-F5C1-450B-B867-170AC6E91636 Q36513773-3BD17D48-A3A6-4010-9498-D409ADA491B8 Q36983736-ACAAA429-2D96-425A-AEBF-77598899D2CD Q37114392-3E504251-77D7-4C29-9B05-513F4FE8DD94 Q37307811-41843B74-A7DA-4524-AA68-291496225100 Q37346110-B51FFE00-DCE1-405F-9BB4-CD182BB37771 Q37390232-473EEF37-2B79-4606-B485-A2FC525E06A4 Q37481981-A464B227-D245-46D4-9A51-AF873999237A Q37601706-A1712C95-5911-4B4D-A15E-2D4FC819278A Q37619915-07488721-6987-4BF6-B567-40FCD31EB10B Q38028808-E0E7CA8B-0DB3-461C-B744-B3287F10CD88 Q38068816-CFB00BE6-A7E6-4014-ACA8-24EED7909B9D Q38105123-D4B84A28-8686-4012-A48F-797EA658E671

P2860

High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia.

http://www.wikidata.org/entity/Q54309630

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

High-throughput sequencing det ...... cute T lymphoblastic leukemia.

@en

High-throughput sequencing det ...... cute T lymphoblastic leukemia.

@nl

type

label

High-throughput sequencing det ...... cute T lymphoblastic leukemia.

@en

High-throughput sequencing det ...... cute T lymphoblastic leukemia.

@nl

prefLabel

High-throughput sequencing det ...... cute T lymphoblastic leukemia.

@en

High-throughput sequencing det ...... cute T lymphoblastic leukemia.

@nl

P1433

Q54309630-75A5A572-8E88-4208-B92C-C043A93D54DC

P1476

Q54309630-2750DF57-B12B-48F8-BFF3-527FC90C47E1

P2093

Q54309630-27723A65-9ADF-404F-B5E3-39BA947F6DAB

Q54309630-5340D517-C782-4128-B8E9-B3209B6E26E0

Q54309630-53A98CBF-8620-45BD-999D-E3B79DA9CCE5

Q54309630-927DA369-7513-4FE6-B13D-DF21E73E2758

Q54309630-B267C2DA-D85F-4A4C-8D53-6354B3E5D23A

Q54309630-D8D4595B-6786-49E6-99AF-11ADC76981DD

Q54309630-E1EE82E8-28D8-4AF6-AF66-8DD7EFFF1463

Q54309630-F9699E1E-5970-4379-8ACA-126188960D41

Q54309630-FAED2F0C-3EF6-4FFA-BB76-FC93C152FFCC

P2860

Q54309630-1977C6AB-D64F-4FDD-8F8C-A517C77692CA

Q54309630-2D7AACF0-4054-4780-88BD-DE5D31B83FCB

Q54309630-3B13089C-B367-483B-BCD5-7E96F1FE4C85

Q54309630-3BEDD4B0-498E-4384-A11A-42B962BDBA56

Q54309630-3C0CCDA2-69B2-4406-954A-DFE2FB552267

Q54309630-42F21CAA-A6B5-4411-957B-227726C58082

Q54309630-5936182A-3CF8-4BB3-A814-D8983C2E65E9

Q54309630-5C1067EA-3E82-49E8-AE7D-C14F4F3E7CC7

Q54309630-6F3D9D5E-C09A-4656-A861-446C5D52AE88

Q54309630-96194FD1-DDD2-46CA-A110-7810F3627CDF

P304

Q54309630-3CBD2348-C541-4128-BDB9-B7764B27F81E

P31

Q54309630-0BC0C448-3883-409D-8798-F4F1BCC137D7

P356

Q54309630-BF140246-88B2-4F83-89D1-B78C62BFA8B2

P407

Q54309630-4EEB9953-921E-4159-908A-F34DAED6DD14

P433

Q54309630-643A1B6D-ABEC-4B7D-B35C-3753845B54A8

P478

Q54309630-1E951D41-A854-43AB-ADE2-0C839E56A2B2

P50

Q54309630-B5F52CD6-6671-4577-871B-CB13E7473F1F

P577

Q54309630-72C72BA7-D21D-42EB-952C-3712A2D4F8AA

P698

Q54309630-EFFC7480-E2B2-4D7E-9F9D-840057D4C462

P921

Q54309630-E0ED461A-34AF-48E7-BF5C-6D98DD42977D

P356

SCITRANSLMED.3003656

P1433

Science Translational Medicine

P1476

High-throughput sequencing det ...... cute T lymphoblastic leukemia.

@en

P2093

Anna Sherwood

http://www.w3.org/2001/XMLSchema#string

Brent L Wood

http://www.w3.org/2001/XMLSchema#string

Daniel E Sabath

http://www.w3.org/2001/XMLSchema#string

David Wu

http://www.w3.org/2001/XMLSchema#string

Harlan Robins

http://www.w3.org/2001/XMLSchema#string

Harvey A Greisman

http://www.w3.org/2001/XMLSchema#string

Jonathan R Fromm

http://www.w3.org/2001/XMLSchema#string

Mignon L Loh

http://www.w3.org/2001/XMLSchema#string

Stuart S Winter

http://www.w3.org/2001/XMLSchema#string

P2860

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: implications for minimal residual disease detection.

Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia

Deep sequencing of the human TCRγ and TCRβ repertoires suggests that TCRβ rearranges after αβ and γδ T cell commitment

Cell of origin strongly influences genetic selection in a mouse model of T-ALL

Overlap and effective size of the human CD8+ T cell receptor repertoire

Progress of minimal residual disease studies in childhood acute leukemia.

Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells.

P304

134ra63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3003656

http://www.w3.org/2001/XMLSchema#string

P407

P433

134

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Kimberly P Dunsmore

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22593176

http://www.w3.org/2001/XMLSchema#string

P921